NUCRYST Pharmaceuticals Corp. (NCST) Dividend Summary

Nucryst Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation based on its nanocrystalline silver technology. Advanced wound care products with the company's Silcryst coatings are sold by Smith & Nephew plc under an exclusive license under its Acticoat trademark. Nucryst is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The company has developed its nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient.

Last update 12/21/2009

Dividend Yield Summary

	2009	2010	2011	2012	2013	2014
Dividends	$0.8	$0	$0	$0	$0	$0
Price	$0.94	$0	$0	$0	$0	$0
Yield	85.11 %	0 %	0 %	0 %	0 %	0 %

Earnings Information

Next Report Date	11/05/2009
Estimated EPS (year)	$0.00
Estimated EPS (quarter)	$0.00
Estimated EPS Growth	0.00%
Payout Ratio	0.00%
Payout change vs. 5 year average	0.00%

Dividend/Split History

Date	Amount Per Share/Split Ratio	Type
2009-02-25	$0.80000	Dividend

Company Profile

NUCRYST PHARMAC
50 Audubon Road
Suite B
Wakefield, MA 01880, USA
Phone: 781 224-1444
Fax: 781 246-6002
Web: www.nucryst.com
Email: info@nucryst.com

Key Information

Sector:	Medical
Industry:	DRUGS
Fiscal Year End:	December
Next Reported Fiscal Year:	2008
Last Reported Quarter:	6/30/2009

Management

Chmn.; Presi.; C.E.O.	Thomas E. Gardner
V.P.; Finance.; Admn.; C.F.O.; Princ. Acctg. Off.	Eliot M. lurier
V.P. ; Research Devlopment	Katherine J. Turner, Ph.D.
V.P.; Manufacturing Operations	David C. Mcdwell
V.P.; Genl. Counsel.; Corp. Sec.	Carol L. Amelio

Competitors

SIC Code: 3841

Ticker	Company Name
JNJ	JOHNSON & JOHNS
PFE	PFIZER INC
GSK	GLAXOSMITHKLINE
SNY	SANOFI-SYNT-ADR
RHHBY	ROCHE HLDG LTD
NVS	NOVARTIS AG-ADR
AZN	ASTRAZENECA PLC

NUCRYST Pharmaceuticals Corp. NCST (NSDQ) Financial Ratios

P/E
Current FY Estimate	0.00
Trailing 12 Months	0.00
PEG Ratio	0.00

EPS Growth
vs. Previous Year	77.78%
vs. Previous Quarter	66.67%

Sales Growth
vs. Previous Year	4.97%
vs. Previous Quarter	19.11%

Price Ratios
Price/Book	0.74
Price/Cash Flow	0.00
Price/Sales	0.86

ROE
06/30/2009	-7.34
03/30/2009	-10.00
12/30/2008	-11.37

ROA
06/30/2009	-6.34
03/30/2009	-8.83
12/30/2008	-10.17

Current Ratio
06/30/2009	3.48
03/30/2009	5.44
12/30/2008	10.80

Quick Ratio
06/30/2009	2.77
03/30/2009	4.37
12/30/2008	9.82

Operating Margin
06/30/2009	-11.40
03/30/2009	-18.09
12/30/2008	-22.48

Net Margin
06/30/2009	-2.82
03/30/2009	-9.41
12/30/2008	-14.22

Pre-Tax Margin
06/30/2009	-2.79
03/30/2009	-9.36
12/30/2008	-14.16

Book Value
06/30/2009	1.27
03/30/2009	1.20
12/30/2008	2.09

Inventory Turnover
06/30/2009	3.16
03/30/2009	3.15
12/30/2008	3.63

Debt-to-Equity
06/30/2009	0.00
03/30/2009	0.00
12/30/2008	0.00

Debt-to-Capital
06/30/2009	0.00
03/30/2009	0.00
12/30/2008	0.00

Quick Quote

Updated as of N/A

Last Trade:	0.00
Trade Time:	N/A
Change:	0.00
Open:	0.50
High:	N/A
Low:	N/A
Volume:	0

Security Details

Exchange	NSDQ
CUSIP
Split Date	-
Split Factor	0
Shares outstanding	18.33
Beta	0.67

Detailed Quote as of 09/10/2009

Price	$0.94
52 Week High	$1.30
52 Week Low	$0.30
Price Change (4 weeks)	$46.88
Price Change (12 weeks)	$64.94
Price Change (YTD)	$4.44
Price Change (4 weeks) vs. S&P	$42.43
Price Change (12 weeks) vs. S&P	$46.70
Price Change (YTD) vs. S&P	$-7.18
Average Daily Volume (20 Days)	31,162
Market Capitalization	$17.23

Price History

Earning Announcement

Last Confirmation Date	2009-11-12
Next Earnings Announcement Date	2009-11-13
Earnings Quarter	Q3
Announcement Status	Unconfirmed

Investor Conference Call

Date	2009-02-17
Time	09:00:00
URL	Conference Call Information

Last Dividend Payout

Announcement Date	2009-02-12
Record Date	2009-02-17
Pay Date	2009-02-25
Amount Per Share	$0.8

Board Shareholder Meeting

First Quarter	2009-05-06
Second Quarter	2009-08-05
Third Quarter	2009-11-13
Fourth Quarter	2009-02-17